Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

LABORATÓRIOS ATRAL, S.A.

NIF 500162085
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €2,513,166 41 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €2,513,166 41 contracts
A2 · Late Publication €3,367,465,631 1,056 contracts
Contract published to BASE more than 10 days after the signing date
LOW €3,367,465,631 1,056 contracts
A5 · Threshold Splitting €1,178,083 22 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €1,178,083 22 contracts
A6 · Low Competition €382,693 10 contracts
Only one bidder participated in a competitive procedure
MEDIUM €382,693 10 contracts
A9 · Abnormal Price Reduction €4,390,624,417 689 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €4,390,624,417 689 contracts
C3 · Missing Mandatory Fields €562,064 15 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €562,064 15 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

30
€407,867,957
91
€288,571,025
41
€185,556,855
30
€170,125,533
22
€168,858,698
24
€151,483,604
14
€151,238,317
97
€149,260,338
28
€148,844,866
122
€141,186,112
56
€131,642,247
24
€131,314,083
14
€131,058,654
10
€122,269,247
32
€116,872,443
20
€116,361,387
16
€114,826,201
35
€114,499,743
7
€107,335,718
17
€106,127,642
Page 1 of 4 · 66 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 1 · 15 contracts

CP-24/0034 - Aquisição de medicamentos e reagentes diversos para o PT EMT (Portuguese Emergency Medical Team)
PT · 11184519 · Concurso público
C3 · Missing Mandatory Fields
€728 2024-12-27
31/396/2025 - Medicamentos "Benzilpenicilina Benzatínica, Potássica e Sódica"
PT · 11263727 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€6,646 2024-12-18
Amoxicilina
PT · 11198994 · Ajuste Direto Regime G...
C3 · Missing Mandatory Fields
€1,225 2024-12-16
CP 2023/304 - Acordo-Quadro para fornecimento de Medicamentos do grupo 4: sangue, na área da saúde, anúncio em DRE nº 1867/2023 e data de publicação a 09/02/2023
PT · 11460726 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€219,826 2024-12-03
Aquisição de Medicamentos Exclusivos ATRAL 2025
PT · 11342527 · Ajuste Direto Regime G...
C3 · Missing Mandatory Fields A6 · Low Competition
€8,211 2024-12-02
41/146/2025 Medicamentos anti-infeciosos
PT · 11147929 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€34,665 2024-11-29
31/130/2025 - Medicamentos anti-infeciosos
PT · 11521202 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€738 2024-11-08
AMPICILINA 1000 MG PÓ SOL INJ FR IM IV
PT · 11209003 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€3,960 2024-10-21
BENZILPENICILINAS
PT · 11156562 · Ajuste Direto Regime G...
C3 · Missing Mandatory Fields
€1,306 2024-05-17
864/2024 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/491 - Medicamentos do foro oncológico e imunomoduladores, 2021/6 - Medicamentos do foro oncológico e imunomoduladores, 2023/492 - Medicamentos anti-infeciosos, 2022/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH, 2021/47 - Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas para aquisição de medicamentos
PT · 11334472 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€25,557 2024-03-28
Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2021/55, 2022/55, 2023/304 e 2023/491 para as instituições do SNS
PT · 11230883 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€76,968 2024-03-20
Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2021/55, 2022/55, 2023/304 e 2023/491 para as instituições do SNS
PT · 11295722 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€26,874 2024-03-14
Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2021/55, 2022/55, 2023/304 e 2023/491 para as instituições do SNS
PT · 11340254 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€94,140 2024-02-26
Medicamentos anti-infeciosos
PT · 11265762 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€1,512 2024-02-22
MEDICAMENTOS DIVERSOS AQ 2020/5
PT · 11232138 · Ao abrigo de acordo-qu...
C3 · Missing Mandatory Fields
€59,703 2024-01-04
Overview
Total Value Won
€4,408,130,949
Contracts Won
1,473
Score 52450 · CRITICAL RISK
NIF
500162085
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.L. [P-05ef]
    Vogal
    since 2008-06-16
  • A.L. [P-05ef]
    Vogal
    since 2011-03-21
  • A.L. [P-05ef]
    Vogal
    since 2014-06-05
  • A.L. [P-05ef]
    Vogal
    since 2016-06-15
  • B.A. [P-f99d]
    Administrador
    since 2021-03-22
  • C.A. [P-4f37]
    Vogal
    since 2016-06-15
  • E.E. [P-f252]
    Administrador
    since 2016-09-15
  • E.E. [P-f252]
    Vogal
    since 2017-07-07
  • E.E. [P-f252]
    Vogal
    since 2021-03-22
  • F.J. [P-bf44]
    Presidente
    since 2016-06-15
  • F.J. [P-bf44]
    Presidente
    since 2017-07-07
  • F.J. [P-bf44]
    Presidente
    since 2021-03-22
  • F.P. [P-4509]
    vogal
    since 2018-07-24
  • F.P. [P-4509]
    Vogal
    since 2021-03-22
  • J.M. [P-4d9d]
    efetivo
    since 2021-03-22
  • J.M. [P-ff6b]
    Vogal
    since 2008-06-16
  • M.H. [P-9a56]
    Secretária da administração
    since 2017-07-07
  • M.H. [P-9a56]
    Secretária da administração
    since 2021-03-22
  • P.M. [P-d850]
    efetivo
    since 2021-03-22
  • S.C. [P-30bb]
    suplente
    since 2021-03-22
  • S.A. [P-2336]
    Presidente
    since 2008-06-16
  • S.A. [P-2336]
    Presidente
    since 2011-03-21
  • S.A. [P-2336]
    Presidente
    since 2012-03-16
  • S.M. [P-e560]
    Vogal
    since 2009-06-19
  • S.M. [P-e560]
    Vogal
    since 2011-03-21
  • S.M. [P-e560]
    Vogal
    since 2014-06-05
  • S.M. [P-e560]
    Vogal
    since 2016-06-15
  • T.B. [P-da99]
    efetivo
    since 2021-03-22
  • T.P. [P-ce49]
    Vogal
    since 2012-10-25
  • T.P. [P-ce49]
    Presidente
    since 2014-06-05
  • T.P. [P-ce49]
    Presidente
    since 2016-06-15
  • V.L. [P-ba4e]
    Vogal
    since 2012-10-25
  • V.L. [P-ba4e]
    Vogal
    since 2014-06-05
  • D.A. [P-c2b1]
    Fiscal Único
    since 2025-12-16
  • E.Y. [P-6b36]
    Fiscal Único
    since 2020-01-30
  • J.C. [P-75e0]
    Fiscal Único
    since 2025-12-16
  • P.J. [P-8c94]
    Fiscal Único
    since 2008-06-16
  • P.J. [P-8c94]
    Fiscal Único
    since 2011-03-21
  • P.A. [P-9f96]
    Fiscal Único
    since 2008-06-16
  • P.A. [P-9f96]
    Fiscal Único
    since 2011-03-21
  • R.M. [P-e62a]
    Fiscal Único
    since 2020-01-30
  • V.A. [P-3c97]
    Fiscal Único
    since 2014-06-05
  • V.M. [P-e856]
    Fiscal Único
    since 2014-06-05
  • C.A. [P-4f37]
    Vogal
    2017-07-07 → 2017-12-05
  • J.M. [P-ff6b]
    Administrador-Delegado
    2011-03-21 → 2013-02-22
  • T.P. [P-ce49]
    Vogal
    2008-06-16 → 2009-06-18
  • V.L. [P-ba4e]
    Vogal
    2016-06-15 → 2016-10-14
  • B.A. [P-f99d]
    Fiscal Único
    2017-07-07 → 2020-01-30
  • M.J. [P-20be]
    Fiscal Único
    2017-07-07 → 2020-01-30
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned